Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II

Melanoma Research

Volumn 11, Issue 6, 2001, Pages 587-599

  Vogt, T ^a   McClelland, M ^b   Jung, B ^b   Popova, S ^a   Bogenrieder, T ^a   Becker, B ^a   Rumpler, G ^a   Landthaler, M ^a   Stolz, W ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

Apoptosis; Cyclooxygenase; Melanoma; NSAIDs; Sulindac

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; SULINDAC SULFIDE; SULINDAC SULFONE;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CELL LINE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MALE; MELANOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CHILD; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DISEASE PROGRESSION; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOENZYME TECHNIQUES; ISOENZYMES; MELANOMA; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SKIN NEOPLASMS; SULINDAC; TUMOR CELLS, CULTURED;

EID: 0035216769     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200112000-00005     Document Type: Article

References (46)

1. Increased expression of cyclooxygenase-2 protein in rat lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine
2. Establishment and characterization of a human lung cancer cell line NCI- H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation
3. Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers
4. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
5. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus
6. Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs
7. Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder
8. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma
9. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma
10. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
11. COX-2 expression is induced by UVB exposure in human skin: Implications for the development of skin cancer
12. The relationship between cyclooxygenase-2 expression and colorectal cancer
13. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas
14. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer
15. COX-2 is expressed in human pulmonary, colonic, and mammary tumors
16. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
17. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor
18. Nonsteroidal anti-inflammatory drugs and cancer prevention
19. Progress in cancer chemoprevention
20. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
21. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels
22. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2
23. Cyclooxygenase-independent induction of p21WAF-1/CIP1, apoptosis and differentiation by L-745,337 and salicylate in HT-29 colon cancer cells
24. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells
25. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction
26. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo
27. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
28. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
29. Human melanoma-mediated inhibition of autologous CD4+ helper tumor-infiltrating lymphocyte growth in vitro
30. Amelioration of B16F10 melanoma lung metastasis in mice by a combination therapy with indomethacin and interleukin 2
31. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
32. Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells
33. Cure of B16F1O melanoma lung metastasis in mice by chronic indomethacin therapy combined with repeated rounds of interleukin 2: Characteristics of killer cells generated in situ
34. Cure of human melanoma lung metastases in nude mice with chronic indomethacin therapy combined with multiple rounds of IL-2: Characteristics of killer cells generated in situ
35. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract
36. Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine-resistant phenotype
37. Integrin expression in human melanoma cells with differing invasive and metastatic properties
38. Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase. Mediation through different signaling pathways
39. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
40. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts
41. Nonsteroidal anti-inflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts
42. Prostaglandins regulate melanoma-induced cytokine production in macrophages
43. Identification of arachidonic acid pathways required for the invasive and metastatic activity of malignant tumor cells
44. Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells
45. Augmented antitumor effect of recombinant human interleukin-1 alpha by indomethacin
46. Indomethacin inhibits kidney metastasis in Bomirski melanoma-bearing hamsters, and modulates natural killer cytotoxic activity of tumor hosts in vivo and in vitro